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The phosphoprotein Dishevelled (Dvl) is a common
essential component of Wnt/b-catenin and Wnt/
planar cell polarity (PCP) signaling pathways. How-
ever, the regulation and significance of Dvl phos-
phorylation are not fully understood. Here, we show
that homeodomain-interacting protein kinase 2
(Hipk2) facilitates protein phosphatase 1 catalytic
subunit (PP1c)-mediated dephosphorylation of Dvl
via its C-terminal domain and that this dephosphory-
lation blocks ubiquitination and consequent degra-
dationmediated by the E3 ubiquitin ligase Itch, which
targets the phosphorylated form of Dvl proteins. Inhi-
bition of Hipk2 or PP1c function reduces Dvl protein
levels and suppresses Wnt/b-catenin and Wnt/PCP
pathway-dependent events in mammalian cells and
zebrafish embryos, suggesting that Hipk2 and PP1c
are essential for maintaining Dvl protein levels that
are sufficient to activate Wnt signaling. We also
show that Wnt-3a, a Wnt/b-catenin ligand, induces
dissociation of the Dvl-Hipk2-PP1c complex and
Dvl degradation under high-cell-density conditions.
This regulation may be a negative feedback mecha-
nism that fine-tunes Wnt/b-catenin signaling.INTRODUCTION
Members of the Wnt family of secreted proteins transduce their
signals through multiple pathways, including the b-catenin and
planar cell polarity (PCP) pathways. In the b-catenin pathway,
Wnt binds to the cell-surface receptor Frizzled and its corecep-
tor, LRP5/6. This Wnt-bound receptor complex recruits the
cytoplasmic phosphoprotein Dishevelled (Dvl1, Dvl2, and Dvl3
in vertebrates) and induces phosphorylation of LRP6. Phosphor-
ylated LRP6 then promotes the disassembly of the b-catenin
degradation complex, leading to the stabilization of cytoplasmic
b-catenin (MacDonald et al., 2011; Niehrs and Shen, 2010).
b-Catenin then migrates into the nucleus, where it forms com-
plexes with Tcf/Lef proteins and activates gene expression.Cell ReRegulation of this pathway controls cell proliferation and fate
determination (Clevers, 2006; Logan and Nusse, 2004). In the
PCP pathway, which regulates cell movement and polarity,
Wnt signals via Dvl to activate members of the Rho family of
small G proteins. The activated G proteins then regulate the re-
modeling of actin filaments (Angers and Moon, 2009). Thus,
Wnt proteins transduce their signals through Dvl in both the
b-catenin and PCP pathways.
Dvl is phosphorylated by various kinases, including CK1d,
CK1ε, CK2, Par1, Plk1, and RIPK4 (Bryja et al., 2007; Cong
et al., 2004; Huang et al., 2013; Kishida et al., 2001; Ossipova
et al., 2005; Willert et al., 1997), and is dephosphorylated by pro-
tein phosphatase-2A (PP2A) (Yokoyama andMalbon, 2007). This
kinase- and phosphatase-mediated regulation of Dvl plays both
positive and negative roles in Wnt signal transduction. Although
the regulation and significance of Dvl phosphorylation are not
fully understood, a recent report showed that the E3 ubiquitin
(Ub) ligase Itch ubiquitinates and destabilizes the phosphory-
lated form of Dvl regardless of whether Wnt signaling is active
(Wei et al., 2012), indicating that Dvl is constitutively destabilized
by phosphorylation. These findings also suggest that the desta-
bilizing-phosphorylation of Dvl must be kept at low levels to
maintain a pool of Dvl proteins available to respond to Wnt stim-
ulation. However, themechanism that controls this phosphoryla-
tion is unclear.
Protein phosphatase 1 catalytic subunit (PP1c) is a member of
the PPP family of serine/threonine phosphatases that regulates a
diverse array of cellular functions (Cohen, 2002). Recently, PP1c
was identified as a positive regulator of Wnt/b-catenin signaling
by two independent functional screenings using cultured cells
(Kim et al., 2013; Luo et al., 2007). Inhibition of PP1c by treatment
with PP1c chemical inhibitors, or overexpression of PP1c nega-
tive regulators, induced the phosphorylation of Axin and pro-
moted its interaction with GSK-3b (Luo et al., 2007). However,
the role of PP1c in regulating Wnt signal transduction is not fully
understood.
Homeodomain-interacting protein kinase 2 (Hipk2) is an evolu-
tionarily conserved serine/threonine kinase that phosphorylates
and regulates several transcription factors, including p53,
CtBP, and c-Myb (Rinaldo et al., 2007). Recent studies show
that Hipk2 and its family proteins bind to and phosphorylate
b-catenin, the E3 Ub ligase bTrCP/Slimb, and Tcf/Lef to modu-





Figure 1. Hipk2 Is Required for Dvl-Medi-
ated Early Embryonic Events in Zebrafish
(A) Hipk2 is required for the stabilization of b-cat-
enin in zebrafish. Zebrafish embryos were injected
with MOs. Extracts were harvested from embryos
at 8 hr postfertilization (hpf) and immunoblotted
with anti-zebrafish b-catenin. a-Tubulin was used
as a loading control.
(B and C) Hipk2 is essential for the b-catenin
pathway-mediated posterior mesoderm formation
and convergent extension (CE). Embryos were
injected with MOs. Panels in (B) show whole-
mount in situ hybridization of d2EGFP, tbx6, or ntla
in OTM:d2EGFP-transgenic zebrafish embryos.
Panels in (C) show whole-mount in situ hybridiza-
tion of ntla and dlx3b or myod1 in zebrafish em-
bryos. Blue, red, and orange two-way arrows
indicate the width of neural plate, the length of
notochord, and the width of myod1-expression
domain, respectively. The percentages of em-
bryos showing similar expression patterns and
total number of MO-injected embryos (n) are
shown under each image. In all images, A, P, V,
and D indicate anterior, posterior, ventral, and
dorsal sides. Scale bar, 200 mm.
(D and E) Hipk2 is required for the protein stability
of endogenous Dvl (D) and exogenous mouse Dvl1
(E) Dvl in zebrafish. Zebrafish embryos were injected with MOs without (D) or with mouse Myc-Dvl1 and hemagglutinin (HA)-GFP mRNA (E). Extracts were
harvested from the embryos at 8 hpf. In (D), embryo extracts were immunoprecipitated and then immunoblotted with anti-Dvl (see te Experimental Procedures for
details). In (E), extracts were immunoblotted with indicated antibodies. GFP was used as a loading control.
See also Figures S1 and S2.skin tissue, Xenopus embryos, and Drosophila (Hikasa et al.,
2010; Kim et al., 2010; Lee et al., 2009; Swarup and Verheyen,
2011; Wei et al., 2007). However, the effects of Hipk2 knock-
down on Wnt signaling in mammalian cells and vertebrate
embryos have not been sufficiently investigated. Our Hipk2-
knockdown experiments in mammalian cells and zebrafish em-
bryos indicate that Hipk2 and PP1c are essential for Dvl protein
stability and signal transduction in both the b-catenin and PCP
pathways. Moreover, our biochemical and functional analyses
show that Hipk2 promotes the recruitment of PP1c to Dvl,
promoting PP1c-mediated Dvl dephosphorylation in a kinase
activity-independent manner, and that this dephosphorylation
stabilizes Dvl by blocking Itch-mediated ubiquitination.
RESULTS
Hipk2 Is Required for Wnt/b-Catenin Pathway Activity
throughout Early Zebrafish Embryogenesis
We previously reported that overexpression of mouse Hipk2 in-
duces the stabilization of exogenous b-catenin in HeLa cells (Lee
et al., 2009). However, the mechanisms by which Hipk2 medi-
ates b-catenin stabilization and the role of this regulation in
vertebrate development remained unclear. Therefore, we inves-
tigated these questions using zebrafish. Because hipk2mRNA is
expressed ubiquitously throughout early embryogenesis in ze-
brafish (Figure S1A), we used this as a model system to investi-
gate Hipk2 function. To examine the effects of Hipk2 inactivation
in zebrafish embryos, we used hipk2 morpholino oligonucleo-
tides (MOs) and hipk2 spl MOs, which block the translation
and splicing of hipk2, respectively (Figures S1B–S1E). Injection1392 Cell Reports 8, 1391–1404, September 11, 2014 ª2014 The Auof hipk2MOs or hipk2 spl MOs dramatically reduced the protein
levels of endogenous b-catenin (Figure 1A), whereas the mRNA
levels of b-catenin were not affected by hipk2MO injection (Fig-
ure S2A). These results suggest that Hipk2 is essential for endog-
enous b-catenin stability in zebrafish embryos. To monitor the
specific role of Hipk2 in the Wnt/b-catenin pathway, we used a
transgenic zebrafish line carrying a Wnt/b-catenin signaling re-
porter construct (OTM:d2EGFP) comprising a destabilized GFP
(d2EGFP) driven by a promoter containing multiple Tcf/Lef bind-
ing sites (Shimizu et al., 2012). d2EGFP expression was attenu-
ated by hipk2 knockdown using MOs at 4, 8, and 10 hr postferti-
lization (hpf) (Figures 1B, S2B, and S2C), suggesting that Hipk2 is
required for b-catenin pathway activation throughout early ze-
brafish embryogenesis. Consistent with this, hipk2 knockdown
also inhibited induction of the posterior mesodermal marker
tbx6 at 8 hpf (Figures 1B and S2A), and the posterior neural tis-
sue markers pax2a and eng2a (Figure S2D) and the paraxial
mesoderm marker myod1 (Figure 1C) at 10 hpf, all of which are
positively regulated by the b-catenin pathway (Hoppler et al.,
1996; Kelly et al., 1995; Lekven et al., 2001, 2003; Szeto and
Kimelman, 2004). By contrast, hipk2 knockdown had no effect
on the expression of a posterior mesoderm marker gene, ntla,
at 8 hpf (Szeto and Kimelman, 2004) (Figure 1B). In addition,
anterior brain tissue marked by the expression of otx2 was
expanded in hipk2-knockdown embryos (Figure S2D). These
phenotypes are similar to those of zebrafish embryos in which
b-catenin signaling is disrupted (Lekven et al., 2001, 2003; Shi-
mizu et al., 2005; Szeto and Kimelman, 2004). Taken together,
these results suggest that hipk2 is involved in b-catenin
pathway-mediated events during early development.thors
Hipk2 Knockdown Disrupts Convergent Extension
during Gastrulation
Interestingly, hipk2-knockdown embryos also exhibited a b-cate-
nin pathway-independent phenotype. These embryos failed to
extendproperly around the yolk at 14 hpf (FigureS2E). In addition,
their notochords and paraxial mesoderm (marked by the expres-
sion of ntla and myod1, respectively) were short and wide, and
their neural plates (the bordersweremarked by dlx3b expression)
were expanded (Figure 1C). These results suggest that Hipk2 is
involved in convergent extension (CE) during gastrulation.
Hipk2 Is Required for Dvl Protein Stability in Zebrafish
Embryos
The CE phenotype caused by hipk2 knockdown is similar to that
seen in slb/wnt11 and ppt/wnt5b loss-of-function mutants (Hei-
senberg et al., 2000; Kilian et al., 2003).Wnt11 andWnt5b are the
Wnt-5a family ligands that activate the PCP pathway (Angers
and Moon, 2009). Therefore, we hypothesized that Hipk2 might
regulate Dvl, a common essential component of the b-catenin
and PCP pathways. Consistent with our hypothesis, treatment
with BIO, a chemical inhibitor of GSK-3b, effectively reversed
hipk2-knockdown-induced reduction of tbx6 expression (Fig-
ure S2F), while injection of Wnt8 mRNA increased OTM:d2EGFP
activity in control MO-injected embryos, but not in hipk2 spl MO-
injected embryos (Figure S2G). Interestingly, when Hipk2 protein
expression was suppressed in zebrafish embryos by hipk2 spl
MO, the amount of the proteins reacting with anti-Dvl was
reduced (Figure 1D, top). These proteins were confirmed to be
Dvl family proteins, as injection of translation-blocking MOs
against dvl2 and dvl3a, which are zebrafish Dvl family genes ex-
pressed in early embryos (Angers et al., 2006), similarly reduced
these proteins (Figure 1D, bottom). In addition, the antibody
recognized zebrafish Dvl2 and Dvl3a proteins that were overex-
pressed in human embryonic kidney 293 cells (Figure S2H). We
also observed that injection of hipk2 spl MOs led to a marked
reduction in the protein levels of exogenous mouse Dvl1 (Fig-
ure 1E). These results suggest that Hipk2 is required for Dvl pro-
tein stability in zebrafish embryos and that reduced levels of Dvl
may result in the inhibition of b-catenin and PCP pathway-medi-
ated events in hipk2-knockdown embryos.
Hipk2 Stabilizes Dvl Protein in a Kinase Activity-
Independent Manner
To determine whether Hipk2 is involved in Dvl stabilization in
mammalian cells, we knocked down Hipk2 in human HeLa cells.
Hipk2 small interfering RNA (siRNA) treatment reduced not only
the expression of Hipk2 mRNA (Figure S3A) but also the protein
levels of endogenous Hipk2 and Dvl (Figure 2A), exogenous
mouse Dvl1 (Figure 2B; lane 2), and human Dvl2 and Dvl3 (Fig-
ure S3B). In addition, Hipk2 RNAi enhanced the degradation
and decreased the stability of endogenous Dvl proteins (Fig-
ure S3C). By contrast, overexpression of Hipk2 inhibited the
degradation and prolonged the stability of endogenous and
exogenous Dvl1 (Figures S3D and S3E), resulting in increased
Dvl protein levels (Figure 2C; lane 2) in HeLa cells. These results
suggest that Hipk2 is essential for Dvl stability in mammalian
cells. We also found that Hipk2 RNAi inhibited Wnt-3a-induced
accumulation of active b-catenin (Figure S3F) and expressionCell Reof the b-catenin pathway target gene, Axin2 (Figure S3A), and
decreased the activity of the b-catenin pathway reporter
(TOPFLASH) (Figure S3G, lane 3). Taken together, these results
suggest that Hipk2 sustains Wnt/b-catenin signaling, probably
through Dvl protein stabilization in mammalian cells.
We next examined the physical interaction between Dvl and
Hipk2. EndogenousDvl2 proteinswere found to coimmunopreci-
pitate with anti-Hipk2 (Figure S4A), indicating that endogenous
Hipk2 forms a complex with endogenous Dvl. To investigate
which region of Dvl or Hipk2 is required for complex formation,
we examined the ability of deletion mutants of Dvl1 (Figure S4B)
and Hipk2 (Figure 2D) to form complexes. Endogenous Hipk2
coimmunoprecipitated with wild-type Dvl1 (WT), DDIX, and
DCT, but not with Dvl1 DDEP (Figures S4C and S4D), indicating
that the region around the DEP domain (371–559) is essential
for the interaction between Dvl1 and Hipk2. On the other hand,
Dvl1 bound to Hipk2 WT, HC, and C, but not to Hipk2 N and H
(Figure 2E), suggesting that Hipk2 associates with Dvl via its
C-terminal domain. We also found that overexpression of Hipk2
WT, HC, and C, but not of Hipk2 N and H, increased Dvl1 protein
levels (Figure 2C). In addition, the Hipk2 RNAi-induced reduction
in Dvl levels was reversed by expression of Hipk2 WT and C, but
not Hipk2 N (Figure 2B), indicating that the C-terminal domain is
sufficient for Hipk2-induced Dvl stabilization but that the kinase
domain is not required. Consistent with this, overexpression of
a kinase-negative Hipk2 mutant, Hipk2 KN, also increased Dvl1
protein levels (Figure 2F), suggesting that Hipk2 stabilizes Dvl in
a kinase activity-independent manner. Furthermore, in zebrafish
embryos, the hipk2 spl MO-induced reduction of OTM:d2EGFP
activity and CE defects were effectively rescued by injection of
Hipk2 WT, C, or KN mRNA (Figures 2G, 2H, S2I, and S2J).
Hipk2KNmRNA injection also rescued thehipk2 splMO-induced
reduction of tbx6 expression (Figure S2J). By contrast, injection
of Hipk2 N had little effect on hipk2 spl MO-induced defects (Fig-
ures 2G, 2H, and S2I). These results suggest that the C-terminal
domain is sufficient for Hipk2-mediated Dvl regulation in vivo.
We next tested whether Hipk2 potentiates Dvl-mediated
signaling. Activated endogenous and exogenous Dvl localizes
in characteristic cytoplasmic punctate structures (Dvl signalo-
somes), which are indicative of active Wnt signaling (Schwarz-
Romond et al., 2007). Some HeLa cells expressed Myc-tagged
Dvl1 (Myc-Dvl1) in punctae, whereas the rest contained diffuse
cytoplasmic Myc-Dvl1 (Figure S3H). Coexpression of Hipk2
WT or C, but not coexpression of Hipk2 N, increased the per-
centage of cells containing Dvl1 signalosomes (Figures S3H
and S3I), suggesting that Hipk2 facilitates Dvl signaling via its
C-terminal domain. Consistent with this, Dvl1-induced activation
of TOPFLASH was increased upon coexpression of Hipk2 WT or
C, but not coexpression of Hipk2 N (Figure S3J). In addition, pro-
tein levels of exogenous b-catenin were also increased by coex-
pression of Hipk2 WT, KN, or C (Figure S3K). Altogether, these
results suggest that Hipk2-mediated Dvl stabilization positively
regulates Dvl signaling.
Hipk2 Stabilizes Dvl by Promoting PP1c-Mediated
Partial Dephosphorylation of Dvl
Dvl is a phosphoprotein (Bryja et al., 2007). Consistent with this,








Figure 2. Hipk2 Regulates Dvl Stability in a
Kinase Activity-Independent Manner in
Mammalian Cells and Zebrafish
(A) Hipk2 is required for endogenous Dvl stability in
HeLa cells. Cells were treated with either control
siRNA or Hipk2 siRNA #1 or #2, and cell extracts
were then were immunoblotted with anti-Dvl1/2/3
(which recognizes all types of Dvl), anti-Hipk2, and
anti-b-tubulin (b-tub). b-tub was used as a loading
control. Relative Dvl protein levels were calculated
by determining the ratio of Dvl to b-tub. Values are
presented below the top panel as the relative
percentage.
(B) Hipk2 WT and C, but not Hipk2 N, reversed
the Hipk2-knockdown-induced reduction in Dvl
expression. HeLa cells were treated with either
control siRNA or Hipk2 siRNA#1 and then trans-
fected with Myc-Dvl1 and Myc-tagged GFP (Myc-
GFP) with or without Flag-tagged human Hipk2
(Flag-Hipk2) WT, N, and C.
(C) Hipk2 increased the Dvl protein levels via its
C-terminal domain. HeLa cells were transfected
withMyc-Dvl1 andMyc-GFPwith empty vector ()
or Flag-Hipk2 WT, N, HC, H, or C.
(D) Schematic diagram of the human Hipk2
deletion mutants. Kinase, kinase domain; HD,
homeodomain-interacting domain; PEST, PEST
sequence.
(E) The C-terminal domain of Hipk2 is essential
and sufficient for binding to Dvl. HeLa cells were
transfected with empty vector () or Flag-tagged
human Hipk2 (Flag-Hipk2) WT, N, HC, H, or C.
The cell extracts were mixed with extracts pre-
pared from cells transfected with Myc-Dvl1 and
then immunoprecipitated with anti-Flag. Immu-
noprecipitated complexes were then immuno-
blotted with indicated antibodies. The expression
of Myc-Dvl1 proteins in cell extracts was con-
firmed by immunoblotting with anti-Myc (‘‘Input’’
lane).
(F) Hipk2 increases the protein level of Dvl1 in a
kinase activity-independent manner. HeLa cells
were transfected with Dvl1, Myc-tagged mouse
Hipk2 (Myc-Hipk2) WT and KN, and Myc-GFP, as
indicated.
(G and H) Hipk2 regulates the b-catenin pathway-
mediated posterior mesoderm formation and CE
via its C-terminal domain. Embryos were injected with MOs with or without human Hipk2 WT, N, or C mRNA. Panels show whole-mount in situ hybridization of
d2EGFP in OTM:d2EGFP-transgenic zebrafish embryos (G) or ntla and dlx3b in nontransgenic zebrafish embryos (H) fixed at the indicated stages. The per-
centages of embryos showing similar expression patterns and total number of MO-injected embryos (n) are shown under each image.
See also Figures S2 and S3.slowly than Dvl1 proteins treated with l protein phosphatase
(lPPase) on SDS-PAGE gels (Figure 3A). Coexpression of
Hipk2 accelerated the migration of some Dvl1 proteins, but
they still migrated more slowly than phosphatase-treated Dvl1
(Figure 3A). These results suggest that Hipk2 may promote the
conversion of Dvl from a highly phosphorylated form to a lesser
phosphorylated form. A previous report showed that PP1c is
essential for b-catenin pathway activation (Luo et al., 2007).
Interestingly, coexpression of PP1c enhanced Dvl1-induced
activation of TOPFLASH in HeLa cells (Figure S5A, lane 4) but
did not affect TOPFLASH activity in the absence of Dvl1 (Fig-
ure S5A, lane 2), suggesting that PP1c cooperates with Dvl to
promote b-catenin signaling. Therefore, we analyzed whether1394 Cell Reports 8, 1391–1404, September 11, 2014 ª2014 The AuPP1c participates in Hipk2-mediated Dvl regulation. In in vitro
phosphatase assays, lPPase and the known Dvl phosphatase,
PP2A, effectively dephosphorylated Dvl1 proteins purified from
HeLa cells in the absence of Hipk2 (Figure 3B, lanes 1, 3,
and 8). By contrast, purified PP1c was unable to dephosphory-
late Dvl1 in the absence of Hipk2 (Figure 3B, lane 6). However,
in the presence of Hipk2, PP1c treatment induced partial
dephosphorylation of Dvl1 (Figure 3B, lane 7), indicating that
PP1c directly dephosphorylates Dvl in a Hipk2-dependent
manner. It is worth noting that although incubation with Hipk2
and PP1c reduced the degree of phosphorylation of Dvl1, low
levels of Dvl1 phosphorylation remained, suggesting that PP1c







Figure 3. Hipk2 Promotes PP1c-Mediated
Dvl Dephosphorylation and Consequent
Stabilization in Mammalian Cells
(A) Hipk2 promotes the partial dephosphorylation
of Dvl1 in vivo. HeLa cells were transfected
with Myc-Dvl1 and Hipk2. Cell lysates were
incubated with or without lPPase and then im-
munoblotted with anti-Myc. To clearly show the
migration-shift of Dvl1 proteins, equal quantities
of Dvl1 proteins were resolved on both 7% and
5%–10% gradient gels. High- and low-level
phosphorylated forms of Dvl (high level-P and low
level-P) and nonphosphorylated Dvl (non-P) are
indicated.
(B) PP1c partially dephosphorylates Dvl1 in a
Hipk2-dependent manner in vitro. Aliquots of
Dvl1 proteins were incubated with lPPase, PP2A
catalytic subunit, PP1c, and Hipk2 and then
immunoblotted with indicated antibodies.
(C) Hipk2 promotes the association of Dvl1 with
PP1c. HeLa cells were transfected with Flag-
Hipk2 and its deletion mutants, Myc-Dvl1, and
Halo-PP1c as indicated. Cell extracts were
immunoprecipitated with anti-Halo. Immunopre-
cipitated complexes were immunoblotted with
indicated antibodies. Expression of Dvl1 and
Hipk2 was confirmed by immunoblotting whole-
cell extracts (WCE) with indicated antibodies.
(D and E) Endogenous Dvl proteins are degraded
by the proteasome in the absence of PP1c activ-
ity. HeLa cells were treated with either control
siRNA or PP1c siRNA #1 or #2 (D) or with DMSO
(), 2 nM CalA, and 20 mMMG132 for 3 hr (E). Cell
lysates were immunoblotted with indicated anti-
bodies. Relative Dvl protein levels were calculated
by determining the ratio of Dvl to b-tub. These
values are presented below the panels as the
relative percentages.
(F) PP1c is required for Hipk2–mediated Dvl1
stabilization. HeLa cells were treated with either
control siRNA or PP1c siRNA #1 and then trans-
fected with Myc-Dvl1 WT and Myc-GFP. Cell
lysates were then immunoblotted with indicated
antibodies.
(G) Amino-acid sequence alignment of the PP1c-docking (KITF) motif within vertebrate Dvl proteins. Arrows indicate the conserved phenylalanine residues in the
KITF motif.
(H) The binding of PP1c is essential for Hipk2-induced Dvl stabilization. HeLa cells were transfected with Myc-Dvl1 WT or FA with Myc-GFP with or without
Flag-Hipk2. Cell extracts were then immunoblotted with indicated antibodies.
See also Figures S4 and S5.that in HeLa cells, endogenous PP1c bound to both endogenous
Hipk2 and Dvl2 (Figure S4A). In addition, Dvl1 proteins interacted
with both Hipk2 and PP1c in vitro, and these interactions were
attenuated by lPPase-treatment (Figure S4E), suggesting that
Hipk2 and PP1c preferentially associate with the phosphorylated
form of Dvl. By contrast, coincubation with Hipk2-overex-
pressed cell lysates enhanced the interaction of Dvl1 with
PP1c in vitro (Figure S4F). Moreover, overexpression of Hipk2
WT and C, but not Hipk2 N, induced dephosphorylation of
Dvl1 and enhanced the binding of Dvl1 to PP1c (Figure 3C).
These results suggest that Hipk2 promotes the association of
Dvl1 with PP1c via its C-terminal domain.
To determine the importance of PP1c in the regulation of Dvl
stability, we treated HeLa cells with PP1c siRNA and the PP1cCell Reinhibitors calcyculin A (CalA) and tautomycetin (TMC). PP1c
siRNA treatment reduced the protein levels of endogenous
PP1c and Dvl (Figure 3D), and treatment with CalA or TMC
also reduced the levels of endogenous Dvl proteins (Figure 3E,
lane 3; Figure S5B). In addition, CalA treatment reduced the pro-
tein levels of exogenous Dvl2 and Dvl3 (Figure S5D). Moreover,
treatment with the proteasome inhibitor MG132 reversed the
CalA-induced reduction of endogenous Dvl protein levels (Fig-
ure 3E, lane 4). Because Dvl1 proteins are hyperphosphorylated
in the presence of both MG132 and CalA (Figure S5E), these re-
sults suggest that Dvl proteins are hyperphosphorylated and
consequently degraded by the proteasome in the absence of
PP1c catalytic activity. We also found that treatment with










Figure 4. Hipk2-PP1c Stabilizes Dvl through Dephosphorylating the Conserved CK1 Sites
(A) Amino acid sequence alignment of the C-terminal CK1 phosphorylation regions within vertebrate Dvl proteins. The potential CK1 phosphorylation sites are
indicated by red letters.
(B) Anti-pDvl1 recognizes the phosphorylation of the conserved CK1 sites on Dvl1 C-terminal region. HeLa cells were transfected withMyc-Dvl1WT andmutants as
indicated.Cell lysateswere immunoblottedwith indicatedantibodies.Toclearlyshowthemigration-shift ofDvl proteins,equalquantitiesofDvlproteinswere resolved.
(C) The conserved CK1 sites on Dvl are phosphorylated in zebrafish. Extracts were harvested from the embryos injected withMyc-taggedmouse Dvl1WT and 3A
mRNA at 8 hpf and immunoblotted with indicated antibodies. In (B) and (C), High and low level phosphorylated forms of Dvl are indicated with red and blue
arrowheads, respectively.
(legend continued on next page)
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exogenous Dvl1 proteins (Figures 3F and S5C). These results
suggest that the PP1c activity is required for Hipk2-mediated
Dvl stabilization.
PP1c recognizes and docks with proteins possessing an R/K-
V/I-X-F motif (Egloff et al., 1997). We discovered that all verte-
brate Dvl family proteins (Figure 3G), but not Hipk2 (data not
shown), possess this motif (KITF). We then generated a Dvl1
FA mutant in which the conserved phenylalanine residue (F489)
within the KITF motif was substituted by alanine and examined
its effect in HeLa cells. The protein expression efficiency of the
Dvl1 FA mutant in HeLa cells was much lower than that of Dvl1
WT; however, treatment with MG132 increased the protein level
of Dvl1 FA (Figure S5F), suggesting that Dvl1 FA tends to be
degraded by the proteasome. We confirmed that Dvl1 WT, but
not the FA mutant, bound to endogenous PP1c in the presence
of MG132 (Figure S5G), and overexpression of Hipk2 failed to in-
crease the protein level of Dvl1 FA (Figure 3H). Consistent with
these results, Dvl1 FA exhibited less TOPFLASH-inducing activ-
ity than Dvl1 WT and coexpression of Hipk2 or PP1c failed to
potentiate this activity (Figure S5A, lanes 5 and 6; Figure S5H,
lanes 4 and 5). These results suggest that the binding of PP1c
to Dvl1 is essential for Hipk2 and PP1c-mediated Dvl stabiliza-
tion. Taken together, these data suggest that Hipk2 stabilizes
Dvl by promoting the binding of PP1c to Dvl, resulting in PP1c-
mediated dephosphorylation of Dvl.
Hipk2-PP1c Stabilizes Dvl through Dephosphorylating
Conserved CK1 Sites within the C-Terminal Region
We found that neither Hipk2 overexpression (Figure S4G) nor
CalA treatment (Figures S4H and S4I) significantly affected the
protein levels of Dvl1DCT or its mobility on SDS-PAGE gels,
although both Hipk2 and PP1c interacted with Dvl1DCT (Fig-
ure S4D). These results suggest that the C-terminal region
following the DEP domain contains the Hipk2-PP1c dephos-
phorylation site(s) essential for Hipk2-PP1c-mediated Dvl regu-
lation. A recent report showed that CK1d directly phosphorylates
Dvl2 at the three conserved Ser/Thr residues S594, T595, and
S597 (shown in Figure 4A) within the C-terminal region and that
this phosphorylation has a negative effect on Wnt/b-catenin
signaling (Gonza´lez-Sancho et al., 2013). Therefore, we hypoth-
esized that Hipk2-PP1c stabilizes Dvl through dephosphoryla-
tion of these residues. To test this possibility, we generated an(D) Endogenous Dvl is phosphorylated at the conserved CK1 sites. HeLa cells we
were subjected to immunoprecipitation with anti-Dvl1/2/3 (anti-Dvl). Immunopre
(E) Hipk2-PP1c dephosphorylates Dvl at the conserved CK1 sites in vivo. HeLa ce
then treated with DMSO () or 2 nM CalA and 25 mM MG132 for 3 hr. Cell lysate
(F) Hipk2-PP1c directly dephosphorylates Dvl1 at the conserved CK1 sites. Aliqu
immunoblotted with indicated antibodies. In (E) and (F), relative Dvl phosphorylati
and these values are presented below the panels as the relative percentages.
(G–J) Dvl1 3A is less sensitive to Hipk2 and PP1c than Dvl WT. In (G)–(I), HeLa cell
and then transfected with Myc-Dvl1 WT and 3A, Myc-GFP, and Flag-Hipk2. In (J),
mRNA. Extracts were immunoblotted with indicated antibodies. Relative Dvl1 prot
are presented below the top panel as the relative percentages.
(K–N) Hipk2 regulates the b-catenin pathway through Dvl dephosphorylation in ze
are shown. In (K), class I, weak reduction of OTM:d2EGFP (d2EGFP); class II, stro
reduction of tbx6. In (L) and (N), the distribution of phenotypes in 8 hpf OTM:d2EGF
or without mouse Dvl1 WT or 3A mRNA (40 pg) is shown. n = the total number o
See also Figures S5 and S6.
Cell Reantibody that specifically recognizes Dvl1 phosphorylated at
the conserved CK1 sites S578, T579, and S581 (shown in Fig-
ure 4A). This phospho-Dvl1 (anti-pDvl1) antibody recognized
exogenous Dvl1 WT expressed in HeLa cells (Figure 4B) and ze-
brafish (Figure 4C) and endogenous Dvl in HeLa cells (Figure 4D).
To verify the specificity of the antibody, we generated four Dvl1
mutants, in which S578, T579, or S581 alone or all three residues
were substituted with alanine (S578A, T579A, S581A, and 3A,
respectively). Dvl1 S578A, T579A, and S581A proteins ex-
pressed in HeLa cells were relatively weakly recognized by
anti-pDvl1 (Figure 4B). Dvl1 3A proteins expressed in HeLa cells
(Figure 4B) and zebrafish (Figure 4C) were not detected by anti-
pDvl1 and migrated slightly faster than untreated Dvl1 WT on
SDS-PAGE. These results suggest that S578, T579, and S581
are phosphorylated in mammalian cells and zebrafish, and they
also confirm the specificity of the antibody. It is noteworthy
that the band patterns of Dvl1 WT and 3A expressed in HeLa
cells were different from those expressed in zebrafish (Figures
4B and 4C, bottom). This might reflect the differences in Dvl
phosphorylation/dephosphorylation activity between HeLa cells
and zebrafish embryos. We also observed that coexpression of
Hipk2 reduced the amount of exogenous Dvl1 proteins reacting
with anti-pDvl1 in HeLa cells (Figure 4E). By contrast, treatment
with CalA and MG132 increased the amount of anti-pDvl1-reac-
tive endogenous Dvl1 and exogenous Dvl (Figures 4D and 4E).
Moreover, incubation of Dvl1 proteins expressed in HeLa cells
with Hipk2 and PP1c in vitro reduced the level of anti-pDvl1-
reactive Dvl1 (Figure 4F). These data suggest that Hipk2-PP1c
dephosphorylates Dvl1 at the conserved CK1 sites. Remarkably,
treatment with MG132 alone also slightly increased the phos-
phorylation of endogenous Dvl at these sites (Figure 4D), indi-
cating that Dvl phosphorylated at these sites may be degraded
by the proteasome at a basal condition. Consistent with this,
MG132 treatment slightly increased the protein levels of endog-
enous Dvl (Figure 3E, lane 2), and the protein level of the Dvl1 3A
mutant was relatively higher than that of Dvl1 WT in HeLa cells
(Figures 4G–4I). In addition, Dvl1 3A protein levels were less
affected than Dvl1WT levels by treatment with Hipk2 siRNA (Fig-
ure 4G) or PP1c siRNA (Figure 4H) or overexpression of Hipk2
(Figure 4I). In addition, the Dvl1 3A mutant was more potent
than Dvl1WT in inducing TOPFLASH activation in both untreated
HeLa cells (Figure S5A, lanes 3 and 7; Figure S5H, lanes 2 and 6)re treated with DMSO () or 2 nM CalA and 10 mMMG132 for 3 hr. Cell extracts
cipitates were immunoblotted with indicated antibodies.
lls were transfected with Myc-Dvl1 WT and 3A and Flag-Hipk2. The cells were
s were immunoblotted with indicated antibodies.
ots of Dvl1 proteins were incubated with or without PP1c and Hipk2 and then
on levels were calculated by determining the ratio of phospho-Dvl1 to total Dvl
s were treated with or without control siRNA, Hipk2 siRNA#2, or PP1c siRNA#1
zebrafish embryos were injected with MOs with mouse Myc-Dvl1 and HA-GFP
ein levels were calculated by determining the ratio of Dvl1 to GFP. These values
brafish. In (K) and (M), classes of phenotypes induced by hipk2 spl MO injection
ng reduction of d2EGFP. In (M), class I, weak reduction of tbx6; class II, strong
P-transgenic (L) or nontransgenic (N) zebrafish embryos injectedwithMOswith
f MO-injected embryos.






Figure 5. Hipk2-PP1c Negatively Regulates
Itch-Mediated Dvl Ubiquitination
(A–D) Hipk2 blocks Itch-mediated Dvl ubiquitina-
tion (A) and degradation (B), but not KLHL12-
mediated Dvl ubiquitination (C), and inhibition of
PP1c activity enhances Itch-mediated Dvl ubiq-
uitination (D). HeLa cells were transfected with
human Itch, Flag-tagged human Itch (Flag-Itch),
human KLHL12, Flag-Hipk2, HA-Ub, Myc-Dvl1,
or Myc-GFP and then treated with 25 mM MG132
for 6 hr (A and C) or with DMSO () or 2 nM CalA
with 25 mM MG132 for 6 hr (D). In (A), (C), and (D),
cell extracts were denatured (see the Experimental
Procedures for details) and then subjected to
immunoprecipitation with indicated antibody.
Immunoprecipitated and ubiquitinated Dvl1 was
detected by immunoblotting with indicated anti-
bodies. The expression of Myc-Hipk2, Flag-
Itch, Flag-Hipk2, or KLHL12 was confirmed by
immunoblotting of whole cell extracts with indi-
cated antibody. In (B), cell lysates were immuno-
blotted with indicated antibodies.
(E) Itch RNAi reverses Hipk2 RNAi-induced
reduction of Dvl protein levels.
(F) Dvl1 3A is less sensitive to Itch than Dvl WT. In
(E) and (F), HeLa cells were treated with control
siRNA, Hipk2 siRNA#1, and Itch siRNA (E) or
transfected with Dvl1 WT and 3A, Myc-GFP, and
Itch (F). Cell lysates were immunoblotted with
indicated antibodies. Relative Dvl protein levels
were calculated by determining the ratio of Dvl to
b-tub (E) or GFP (F), and these values are pre-
sented below the top and second panels as the
relative percentages.
See also Figure S5.and cells treated with Hipk2 siRNA and Wnt-3a (Figure S3G,
lanes 4 and 5), and coexpression of Hipk2 or PP1c had no effect
on Dvl1 3A-induced TOPFLASH activity (Figure S5A, lane 8; Fig-
ure S5H, lane 7). Furthermore, the protein level of exogenous
Dvl1 3A was much higher than that of exogenous Dvl1 WT in
hipk2 spl MO-injected zebrafish embryos (Figure 4J). Consistent
with these observations, coinjection of Dvl1 3A mRNA partially
rescued the hipk2 spl MO-induced reduction of OTM:d2EGFP
activity and tbx6 expression, while coinjection of Dvl1 WT
mRNA had little effect (Figures 4K–4N), suggesting that Dvl
dephosphorylation at the C-terminal CK1 sites contributes to
Hipk2-mediated positive regulation of the b-catenin pathway in
zebrafish embryos. Taken together, these results suggest that
Hipk2-PP1c stabilizes Dvl proteins and sustains Dvl-mediated
signaling by dephosphorylating these conserved CK1 sites.
Interestingly, we also found that the CalA treatment-induced
reduction in exogenous Dvl1 protein level (Figure S6A) and the
Hipk2 RNAi-induced reduction in endogenous Dvl2 protein level
(Figure S6B) were reversed by cotreatment with the CK1 inhibi-
tor, D4476, suggesting that CK1 activity counteracts Hipk2 and
PP1c-mediated stabilization of Dvl.
Hipk2-PP1c Blocks the Itch-Mediated Ubiquitination
of Dvl
The above findings raise the possibility that Dvl is hyperphos-
phorylated and degraded via the proteasome in the absence of1398 Cell Reports 8, 1391–1404, September 11, 2014 ª2014 The AuHipk2-PP1c activity. A recent report showed that the E3 Ub
ligase Itch ubiquitinates phosphorylated Dvl (Wei et al., 2012).
Therefore, we examined the relationship between Hipk2-PP1c
and Itch. Overexpression of Itch increased the ubiquitination of
Dvl1 (Figures 5A) and reduced Dvl protein levels (Figure 5B)
and Dvl1-mediated TOPFLASH activity (Figure S5I), whereas
coexpression of Hipk2 reversed the effects of Itch overexpres-
sion (Figures 5A, 5B, and S5I). By contrast, ubiquitination of
Dvl induced by KLHL12, which is another known E3 Ub ligase
for Dvl (Angers et al., 2006), was not affected by Hipk2 coexpres-
sion (Figure 5C). Moreover, CalA treatment enhanced the Itch-
mediated ubiquitination of Dvl (Figure 5D). In addition, inhibition
of Itch protein expression by siRNA treatment reversed Hipk2
RNAi-induced reduction of endogenous Dvl protein levels (Fig-
ure 5E) and Wnt-3a-induced Axin2 expression (Figure S5J).
Furthermore, the Dvl1 3A mutant protein was less sensitive to
Itch than Dvl1 WT (Figure 5F). These results suggest that
Hipk2-PP1c-induced dephosphorylation stabilizes Dvl mainly
through interfering with Itch-mediated ubiquitination.
In Zebrafish Embryos, PP1c Cooperates with Hipk2 to
Sustain Wnt Signal Transduction while Itch Counteracts
Hipk2 Activity
To examine whether PP1c and Itch are involved in Hipk2-medi-
ated Dvl regulation in vivo, we knocked down PP1c and Itch






Figure 6. In Zebrafish, PP1c Cooperates
with Hipk2 to Sustain Wnt Signal Transduc-
tion while Itch Counteracts Hipk2 Activity
(A–C) PP1c is required for the protein stability of
endogenous Dvl (A) and b-catenin (B) and exoge-
nous mouse Dvl1 (C) in zebrafish. Zebrafish em-
bryos were injected with MOs without (A and B) or
with (C) mouse Myc-Dvl1 and HA-GFP mRNA.
Extracts were harvested from the embryos at 8
hpf. In (A), embryo extracts were immunoprecipi-
tated and then immunoblotted with anti-Dvl. In (B)
and (C), extracts were immunoblotted with indi-
cated antibodies.
(D and E) PP1c is required for tbx6 expression and
CE. Embryos were injected with control MO or
ppp1caa MO (2 ng in D, 4 ng in E) with or without
MO-insensitive ppp1caa mRNA. Panels show
whole-mount in situ hybridization of tbx6, ntla, or
dlx3b in zebrafish embryos.
(F) Itch counteracts Hipk2 activity in zebrafish.
Embryos were injected with MOs as indicated.
Panels show whole-mount in situ hybridization of
OTM:d2EGFP (d2EGFP) or tbx6 in OTM:d2EGFP-
transgenic (top) or nontransgenic (bottom) zebra-
fish embryos. In (D)–(F), the percentages of
embryos showing similar expression patterns and
the total number of MO-injected embryos (n) are
shown under each image.ppp1caa and itcha, are expressed ubiquitously throughout early
embryogenesis (Figure S1A). Injection of a translation-blocking
MOs against ppp1caa (Figures S1F and S1G) reduced the pro-
tein levels of endogenous Dvl (Figure 6A), b-catenin (Figure 6B),
and exogenous mouse Dvl1 (Figure 6C) and expression of the
putative b-catenin pathway target gene, tbx6, at 8 hpf (Figure 6D)
and inhibited CE (Figure 6E); however, it had no effect on the
expression of ntla at 8 hpf (Figure 6D). Coinjection of MO-resis-
tant ppp1caa mRNA rescued the ppp1caa MO-induced reduc-
tion of tbx6 activity and CE defects (Figures 6D and 6E). In
addition, BIO treatment reversed the ppp1caa MO-induced
reduction in tbx6 expression (Figure S2K), and low doses of
ppp1caa MO and hipk2 MO acted synergistically to perturb
CE (Figure S2L). These results suggest that PP1c cooperates
with Hipk2 to stabilize Dvl and sustain Wnt signal transduction
in vivo. On the other hand, injection of a translation-blocking
MO against itcha (Figures S1H and S1I) had no significant
effect on OTM:d2EGFP activity and tbx6 expression at 8 hpfCell Reports 8, 1391–1404, Sepand CE (data not shown), while
coinjection of itcha MO reversed the
hipk2 spl MO-induced reduction in OTM:
d2EGFP activity and tbx6 expression
(Figure 6F), suggesting that Itch counter-
acts Hipk2 activity in vivo. It also suggests
that Itcha negatively regulates the b-cate-
nin pathway in hipk2-knockdown zebra-
fish embryos but doesn’t contribute to
Dvl regulation in normal zebrafish early
embryos. Consistent with this finding, in
normal 8 hpf zebrafish embryos, the
phosphorylation level of Dvl was relativelylow (Figure 4C, bottom; Figure 4J, top), and the protein level of
Dvl1 3A mutant, which is insensitive to Itch activity, was similar
to that of Dvl1 WT (Figure 4J). The phosphorylation that induces
Itch-mediated Dvl degradation may be kept at low levels by
Hipk2-PP1c in normal early zebrafish embryos.
Wnt-3a Induces Dissociation of Hipk2 and PP1c from
Dvl, Resulting in Degradation of Dvl under High-Cell-
Density Conditions
We showed that artificial inhibition of Hipk2 or PP1c function
using siRNA, MOs, or chemical inhibitors results in decreased
Dvl protein levels. Interestingly, we discovered that stimulation
with Wnt-3a for 6 hr also reduced the protein levels of endoge-
nous Dvl when HeLa cells were plated at high density (Figure 7A,
lane 4), whereas it failed to induce any obvious changes in Dvl
protein levels in low density cultures (Figure 7B). Consistent
with this, phosphorylation of LRP6, which is induced down-





Figure 7. Wnt-3a Signaling Interferes with Hipk2-PP1c-Mediated Dvl Stabilization under High-Cell-Density Conditions
(A–C)Wnt-3a treatment reduces Dvl protein levels in HeLa cells in amanner dependent on cell density (A, B), and Itch is required for theWnt-3a signaling-induced
reduction of Dvl protein levels (C). In (A) and (B), HeLa cells were untreated or treated with Wnt-3a or Wnt-5a without () or with 10 mMMG132 for the indicated
times under 100% confluent (A, high density) or 40%–50% confluent (B, low density) conditions. In (C), confluent HeLa cells pretreated with control (cont.) siRNA
or Itch siRNA were treated with Wnt-3a for 6 hr. In (A)–(C), cell extracts were immunoblotted with indicated antibodies. Relative Dvl protein levels or pLRP6
(phosphor-LRP6) levels were calculated by determining the ratio of Dvl or pLRP6 to b-tub and are presented below each panel as the relative percentages (Dvl) or
the fold change (pLRP6).
(legend continued on next page)
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sustained at 6 hr after Wnt-3a stimulation in low-cell-density cul-
tures (Figure 7B, lane 4) but was downregulated under high-cell-
density conditions (Figure 7A, lane 4). In addition, Wnt-3a was
more potent in increasing active b-catenin, Axin2 mRNA, and
TOPFLASH activity under high-density culture conditions than
under low-cell-density conditions (Figures S6C–S6E). We also
found that the Wnt-3a-induced reduction of Dvl protein level
and downregulation of LRP6 phosphorylation in high-density
cultures was abrogated by MG132 treatment (Figure 7A, lane
5). Moreover, in Itch siRNA-treated cells, Wnt-3a stimulation
for 6 hr had no effect on Dvl protein levels and strongly induced
LRP6 phosphorylation, even under high-cell-density conditions
(Figure 7C, lane 4). These results suggest that the Wnt-3a-
induced degradation of Dvl occurs in a manner dependent on
Itch and proteasome activity. We also found that Wnt-3a stimu-
lation induced the dissociation of PP1c and Hipk2 from Dvl2 in
HeLa cells under high-cell-density conditions, but not under
low cell density conditions (Figure 7D). In addition, Wnt-3a stim-
ulation induced the phosphorylation of endogenous Dvl at the
C-terminal Hipk2-PP1c dephosphorylation sites (Figure 7E,
lane 2) and reduced the protein level of exogenous Dvl1 WT
under high-cell-density conditions, while it had no effect on the
protein level of Dvl1 3A (Figure 7F). Consistent with these results,
Wnt-3a stimulation effectively induced TOPFLASH activity in
Dvl1 WT-transfected cells under low-cell-density conditions,
but not under high-cell-density conditions (Figure S6E, lanes 3
and 7). By contrast, Wnt-3a strongly induced TOPFLASH activity
in cells transfected with Dvl1 3A regardless of cell density condi-
tions (Figure S6E, lanes 4 and 8). Taken together, it is likely that
under high-cell-density conditions, Wnt-3a induces Itch-medi-
ated Dvl degradation through the disruption of Hipk2-PP1c-Dvl
complex formation and consequent phosphorylation of Dvl at
the C-terminal sites and that these changes attenuate Wnt-3a
signaling. On the other hand, Wnt-5a stimulation had no effect
on either Dvl protein levels (Figure 7A, lane 6; Figure S6F), the
phosphorylation level of the C-terminal sites (Figure 7E, lane 3),
or the binding of Dvl to PP1c and Hipk2 (Figure S6G) under
high-density conditions, suggesting that this regulation is spe-
cific to the b-catenin pathway.
DISCUSSION
The present study shows that Hipk2 and PP1c-mediated partial
dephosphorylation of Dvl is essential for Dvl stability and sus-
tained Wnt signal transduction in mammalian cells and zebrafish(D) Wnt-3a stimulation disrupts Hipk2-PP1c-Dvl complexes under high-cell-dens
treated or treated with Wnt-3a for 2.5 hr under high or low cell density condition a
anti-PP1c (aPP1c), or anti-Hipk2 (aHipk2). Immunoprecipitated PP1c and Hipk2
cated antibodies, respectively. Expression of Dvl2 was confirmed by immunoblo
(E) Wnt-3a stimulation, but not Wnt-5a stimulation, induces the phosphorylation o
density conditions. Confluent HeLa cells were untreated or treated with Wnt-3a or
Dvl1/Dvl2/Dvl3. Immunoprecipitates were immunoblotted with indicated antibodi
of phospho-Dvl1 to total Dvl and these values are presented below the panels a
(F) Dvl1 3A is resistant to Wnt-3a signaling. Confluent HeLa cells pretransfected w
6 hr. Cell extracts were immunoblotted with anti-Myc. Relative Dvl protein levels w
the panels as the relative percentages.
(G) A possible model of Hipk2-PP1c-mediated Dvl stabilization. See text for deta
See also Figure S6.
Cell Reembryos. In normal cells (Figure 7G, left), Dvl proteins are phos-
phorylated at multiple sites. The phosphorylation of conserved
C-terminal sites, probably by CK1, promotes Itch-mediated Dvl
ubiquitination and consequent degradation. At the same time,
Hipk2 binds to Dvl and promotes the association of PP1c with
Dvl and subsequent PP1c-mediated dephosphorylation of Dvl
at the C-terminal sites. As a result of these competitive regula-
tory activities, the cells retain a certain level of Dvl protein
expression, which is required for the activation of Wnt signaling
upon stimulation. If Hipk2 or PP1c is inhibited or does not asso-
ciate with Dvl (Figure 7G, right), the majority of Dvl proteins are
hyperphosphorylated and consequently degraded through
Itch- and proteasome-mediated mechanisms. In this situation,
Wnt ligands are unable to activate signaling.
In this study, we discovered that the unexpected kinase-inde-
pendent function of Hipk2 is essential for Dvl stabilization and
signal transduction by both the b-catenin and PCP pathways.
Overexpression of Hipk2 WT and a kinase domain-lacking
Hipk2 C mutant, but not a Hipk2 N mutant that included the ki-
nase domain, promoted the binding of PP1c to Dvl, stabilization
of Dvl, the formation of Dvl punctae, and Dvl-mediated b-catenin
signaling in HeLa cells. Expression of the kinase-negativemutant
of Hipk2, Hipk2 KN, also increased Dvl stability. Both the Hipk2
knockdown-induced reduction of Dvl protein levels in HeLa cells
and the reduced b-catenin and PCP pathway activities in zebra-
fish embryos were effectively reversed by the expression of
Hipk2 C, but not of Hipk2 N. These findings indicate that the
C-terminal domain of Hipk2 is sufficient for Dvl stabilization
and Wnt signal transduction. We have previously reported that
mouse Hipk2 promotes the stability of b-catenin through its ki-
nase activity in HeLa cells (Lee et al., 2009). In addition, Swarup
and Verheyen (2011) showed recently that mouse Hipk2 and
Drosophila Hipk bind to an E3 Ub ligase of b-catenin, Slimb/
bTrCP, and block Slimb/bTrCP-mediated b-catenin ubiquitina-
tion in a kinase activity-dependent manner in vitro. In the present
study, we showed that overexpression of Hipk2 KN and C
increased the protein levels of exogenous b-catenin but that
they were less potent than Hipk2WT in increasing b-catenin (Fig-
ure S3K). Considering these results with the previous findings,
Hipk2 is likely to promote b-catenin stability via two different
mechanisms. One mechanism is via kinase activity-dependent
regulation. The other is by C-terminal region-dependent regula-
tion, probably through the dephosphorylation and consequent
stabilization of Dvl, as was revealed in this study. Thus,
although Hipk2 regulates b-catenin signaling through multipleity conditions, but not under low-cell-density conditions. HeLa cells were un-
nd cell extracts were subjected to immunoprecipitation with control IgG (cont),
and coimmunoprecipitated Dvl2 were detected by immunoblotting with indi-
tting WCE with anti-Dvl2.
f endogenous Dvl at the Hipk2-PP1c dephosphorylation sites under high-cell-
Wnt-5a for 3 hr. Cell extracts were subjected to immunoprecipitation with anti-
es. Relative Dvl phosphorylation levels were calculated by determining the ratio
s the relative percentages.
ith Myc-Dvl1 WT or 3A andMyc-GFP as indicated were treated with Wnt-3a for
ere calculated by determining the ratio of Dvl to GFP and are presented below
ils.
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mechanisms, kinase-independent Dvl stabilization by Hipk2
appears to be crucial forWnt signal transduction in zebrafish em-
bryos based on the finding that Hipk2-knockdown-induced
interruption of Wnt signal transduction was recovered by the
expression of Hipk2 C.
As mentioned above, a previous report showed that
Drosophila Hipk promotes Drosophila b-catenin stability through
negative regulation of Slimb/bTrCP (Swarup and Verheyen,
2011). Whereas, in this study, we show that Hipk2 positively reg-
ulates b-catenin stability by maintaining Dvl protein levels in
mammalian cells and zebrafish embryos. We also found that
Hipk loss of function or Hipk overexpression had no effect on
the protein level of Dsh in Drosophila wing discs (Figures S7A
and S7B). In addition, we failed to observe any phenotypes asso-
ciated with abnormal PCP in flies in which Hipk gene was over-
expressed mosaically (data not shown). These results suggest
that Drosophila Hipk is not involved in the regulation of Dsh sta-
bility and that Hipk-mediated regulation of Dvl stability is not
conserved in invertebrates.
Our biochemical and functional analyses uncovered that
PP1c participates in Hipk2-mediated Dvl stability regulation.
Overexpression of Hipk2 promoted the dephosphorylation
and stabilization of Dvl proteins in a PP1c catalytic activity-
dependent manner in HeLa cells. PP1c dephosphorylated Dvl
proteins in a Hipk2-dependent manner in vitro. Inhibition of
PP1c induced hyperphosphorylation and consequent degrada-
tion of Dvl in HeLa cells. Thus, Hipk2 and PP1c cooperate to
promote the dephosphorylation and stabilization of Dvl. How-
ever, the mechanism by which Hipk2 promotes the binding of
PP1c to Dvl remains unclear. In the absence of Hipk2, PP1c
fails to interact significantly with Dvl, even though Dvl itself
possesses a PP1c-docking motif (KITF motif). Possibly, Hipk2
binding to Dvl might induce a conformational change that
unmasks the PP1c-docking motif (Figure 7G). Additional
studies are needed to clarify the structural effects of Hipk2
binding to Dvl.
In contrast to our model, in which Hipk2-PP1c-mediated Dvl
dephosphorylation positively regulates b-catenin signaling, a
number of previous studies have reported that Dvl phosphoryla-
tion positively regulates b-catenin signaling (Cong et al., 2004;
Huang et al., 2013; Ossipova et al., 2005; Willert et al., 1997;
Yokoyama and Malbon, 2007). This is probably because Dvl
can be phosphorylated atmultiple sites, andDvl phosphorylation
plays both positive and negative roles in Wnt/b-catenin signal-
ing in a manner dependent on the phosphorylation site. For
example, Dvl1 phosphorylation at S139 and S142 by CK1 (Kli-
mowski et al., 2006) and Dvl2 phosphorylation at S298 and
S480 by RIPK4 (Huang et al., 2013) promote b-catenin signaling,
while CK1-mediated Dvl2 phosphorylation at the C-terminal
conserved sites negatively regulates b-catenin signaling (Gonza´-
lez-Sancho et al., 2013). In the present study, we show that
Hipk2-PP1c dephosphorylates Dvl1 at the C-terminal CK1 sites
but fails to dephosphorylate the Dvl1DCT mutant lacking the
C-terminal region (560–695), indicating that Hipk2-PP1c de-
phosphorylates Dvl1 specifically at the sites that have a negative
effect on b-catenin signaling. This site-specific dephosphoryla-
tion likely enables Hipk2-PP1c to positively regulate b-catenin
signaling.1402 Cell Reports 8, 1391–1404, September 11, 2014 ª2014 The AuOverexpression of Dvl proteins is frequently observed in many
types of cancer, and a correlation between Dvl protein expres-
sion and b-catenin protein expression and histological tumor
grade is reported for several cancers (Mizutani et al., 2005;
Uematsu et al., 2003; Wei et al., 2008). Therefore, Dvl protein
levels must be tightly controlled to fine-tune Wnt/b-catenin
signaling without causing tumors. In the current study, we found
that Wnt-3a treatment induced the dissociation of Hipk2 and
PP1c from Dvl and subsequent phosphorylation of Dvl at the
C-terminal CK1 sites, resulting in Itch- and proteasome-depen-
dent degradation of Dvl under high-cell-density conditions.
This Dvl degradation attenuates Wnt/b-catenin signaling. By
contrast, Wnt-3a signaling had no effect on Dvl stability
under low-cell-density conditions. This high-cell-density-spe-
cific Wnt-3a-induced Dvl degradation might function as a
mechanism for preventing aberrant cell growth in vivo. Although
it is unclear how Wnt-3a signaling induces Dvl degradation in a
cell-density-dependent manner, a previous study reported that
the cadherin-mediated cell-cell adhesion increases the degrada-
tion of cytoplasmic b-catenin and attenuates Wnt-3a signaling
(Maher et al., 2009). In addition, recent studies show that Wnt/
b-catenin signaling crosstalks with the Hippo pathway, which
senses cell-density information (Heallen et al., 2011; Imajo
et al., 2012; Varelas et al., 2010). It will be interesting to examine
whether the cadherin-based adhesion and the Hippo pathway
are involved in the Dvl degradation.
EXPERIMENTAL PROCEDURES
Plasmids, Reagents, and General Experimental Procedures
Details regarding plasmids, reagents, and general experimental procedures
are provided in the Supplemental Experimental Procedures.
Zebrafish Maintenance
Zebrafish (AB, India, OTM:d2EGFP-transgenic fish) were raised and main-
tained under standard conditions. All experimental animal care was performed
in accordance with institutional and national guidelines and regulations. The
study protocol was approved by the institutional review board of the Medical
Institute of Bioregulation.
Detection of Zebrafish Endogenous Dvl Proteins
A total of 90 zebrafish embryos injected with eachMOwere collected and their
yolks were removed, then residual embryonic tissues were lysed. To efficiently
collect endogenous Dvl proteins, the lysates were boiled with 1% SDS (final
concentration) for 5–10 min to denature proteins. This denaturation was per-
formed to unmask the anti-Dvl antigen region by removing proteins that bind
to endogenous Dvl. After removing the excess SDS dissolved in the lysates
by incubation with SDS-eliminant solution A (ATTO), the SDS-binding dena-
tured Dvl proteins were collected by immunoprecipitation with anti-Dvl
(ab106844; Abcam) and then detected by immunoblotting with same antibody.
lPPase Treatment
Cell lysates were incubated with or without lPPase (New England Biolabs) in
PPase buffer at 30C for 1 hr.
In Vitro PP1 Assay
Myc-Dvl1 and Flag-Hipk2 were expressed in HeLa cells and each protein was
immunoprecipitated with anti-Myc or anti-Flag. Immunoprecipitates were pu-
rified by washing five times with PBS containing a high salt concentration
(0.625 M NaCl) and twice with regular PBS. Flag-Hipk2 proteins were then
released from the immunocomplexes using Flag peptides. Aliquots of Myc-
Dvl1 proteins were incubated with 6.25 U of rabbit purified PP1c (New Englandthors
Biolabs), 5.5 mU of purified PP2A catalytic subunit (Cayman), or 1,600 U of pu-
rified lPPase (New England Biolabs) with or without the indicated amounts of
Flag-Hipk2 protein in phosphatase buffer at 30C for 90min. The sampleswere
resolved in 7% gel (Figure 3B) or 5%–10% gradient gel (Figure 4F).
In Vivo PP1 Assay
A high dose of CalA or TMC inhibits the catalytic activity of PP2A. To selectively
inhibit PP1c, cells were treated with CalA (1.25–2.5 nM) and TMC (0.3–3 mM) at
a low dose. We confirmed that treatment with either 2.5 nM CalA or 3 mM TMC
had no effect on the activity of PP2A in HeLa cells (data not shown).
Protein Immunoprecipitation in the In Vivo Ubiquitination Assay
MG132-treated HeLa cells were lysed and boiled with 1% SDS (final concen-
tration) for 5–10 min to denature proteins. After removing the excess SDS
dissolved in the lysates by incubation with SDS-eliminant solution A, the
SDS-binding denatured Dvl proteins were collected by immunoprecipitation
with anti-Dvl (sc-166303) or anti-Myc (Santa Cruz Biotechnology).
Quantification of Protein Levels
The amounts of endogenous Dvl, active b-catenin, phosphorylated LRP6,
b-tubulin and exogenous Dvl1, phosphorylated Dvl1, and GFP proteins were
quantified using ImageJ (NIH), and relative protein levels were calculated by
determining the ratio of each endogenous protein to b-tubulin or each exoge-
nous protein to GFP or Dvl.
MO and mRNA Injections
For all injections (except for those shown in Figure S2L), eachMO (24 ng) and
mRNA was injected along with 3–4 ng of p53 MO at the one-cell stage. Coin-
jection of MOs with p53 MO was performed to eliminate the possibility that
MO-induced phenotypes were due to artificial MO-induced activation of p53
(Robu et al., 2007). Injection of hipk2 MO, hipk2 spl MO, and ppp1caa MO
without coinjection of p53 MO was confirmed to reduce the expression of
tbx6 and had no effect on ntla expression in 8 hpf zebrafish embryos (data
not shown).
ACCESSION NUMBERS
The hipk2 and itcha sequences reported in this paper have been deposited to
the International Nucleotide Sequence Databases under accession numbers
AB830921 and AB863703, respectively.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedure,
seven figures, and one table and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2014.07.040.
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